About the Company
a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PNT News
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio
Lantheus Holdings, Inc. LNTH has been gaining from its focus on pipeline development. The optimism led by a solid ...
Astra to Buy Fusion Pharma in Hunt for New Cancer Treatments
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers snap up ...
AstraZeneca-Fusion deal reignites radiopharma space
In December, Eli Lilly (LLY) closed its $1.4B acquisition of Point Biopharma Global (PNT), a biotech focused on radioligand ...
AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion
Deal will be ‘good for Canada’ as buyer will keep and expand local manufacturing presence, former Fusion chairman says ...
12 Best Biotech Penny Stocks to Invest In
In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...
Cue Biopharma gets grant for T-cell modulatory multimeric polypeptides for immune response modulation
Discover Cue Biopharma's innovative T-cell modulatory polypeptides with a novel homodimer structure for therapeutic applications. Explore the potential of this patented technology for targeted and ...
Biopharma company to create 401 jobs in Wilson
The jobs would be part of a $371 million investment in Wilson County. The announcement came during a meeting of the state ...
2 More Potential Biotech Buyout Targets
M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance ...
Sutro Biopharma files patent for antibody conjugates targeting CD74 for therapy
Discover the latest patent by Sutro Biopharma Inc. for antibody conjugates targeting CD74, offering innovative therapy methods for cancer treatment. Explore the groundbreaking details now!
AstraZeneca bets on next-generation cancer therapy with $2 bln Fusion deal
March 19 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc (FUSN.O), opens new tab ... cancer today receive radiotherapy at ...
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
March 25, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq ... expertise from leading biotechnology and global pharmaceutical companies. “This newly created position reflects the important inflection ...
Jessie J says she’s the opposite of a ‘beige mum’ as she shows off son’s playroom
Later, Jessie posted more on her stories about the room redesign.
Loading the latest forecasts...